Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients
By: Anjali Chouksey and Sanjay Pandey
References
- 1Barnhill JW.
DSM-5® Clinical Cases [Internet] . American Psychiatric Publishing; 2013 [cited 2019 Dec 3]. Available from. DOI: 10.1176/appi.books.9781585624836 - 2Montenegro MA, Scotoni AE, Cendes F. Dyskinesia induced by phenytoin. Arq Neuropsiquiatr. 1999; 57(2B): 356–60. DOI: 10.1590/S0004-282X1999000300002
- 3Koliscak LP, Makela EH. Selective serotonin reuptake inhibitor-induced akathisia. J Am Pharm Assoc JAPhA. 2009; 49(2): e28–36. DOI: 10.1331/JAPhA.2009.08083
- 4Iselin-Chaves IA, Grotzsch H, Besson M, Burkhard PR, Savoldelli GL. Naloxone responsive acute dystonia and parkinsonism following general anaesthesia. Anaesthesia. 2009; 64: 1359–62. DOI: 10.1111/j.1365-2044.2009.06068.x
- 5Madis P, Ülle L, Karin T, Sven J. Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients, Nordic Journal of Psychiatry. 2016; 70(7): 498–502. DOI: 10.3109/08039488.2016.1164245
- 6Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239–45. DOI: 10.1038/clpt.1981.154
- 7Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM. Medication- induced tardive dyskinesia: a review and update. Ochsner J. 2017; 17: 162–74.
- 8D’Abreu A, Friedman JH. Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 570. DOI: 10.5334/tohm.438
- 9Miller LGJ. Jankovic, Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990; 83(5): 525–32. DOI: 10.1097/00007611-199005000-00011
- 10Janno S, Holi M, Tuisku K, Wahlbeck K. Prevalence of neuroleptic induced movement disorders in chronic schizophrenia in patients. Am JPsychiatry. 2004; 161: 60–3. DOI: 10.1176/appi.ajp.161.1.160
- 11Fields JZ, Gordon JH. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sciences. 1982; 30(3): 229–34. DOI: 10.1016/0024-3205(82)90503-3
- 12Glazer W. Estrogen replacement and tardive dyskinesia. Psychoneuroendocrinology. 1985; 10(3): 345–50. DOI: 10.1016/0306-4530(85)90011-3
- 13Zaatreh M. Anticonvulsant-induced dyskinesia. Expert Opinion on Drug Safety. 2003; 2(4): 385–93. DOI: 10.1517/14740338.2.4.385
- 14Morgan JC, Kurek JA, Davis JL, Sethi KD. Insights into pathophysiology from medication-induced tremor. Tremor Other Hyperkinet Mov. 2017; 7: 442 DOI: 10.5334/tohm.374
- 15Carbon M, Kane JM, Leucht S, Correll CU. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis. World Psychiatry. 2018; 17: 330–40. DOI: 10.1002/wps.20579
- 16Shin H-W, Kim MJ, Kim JS, Lee MC, Chung SJ. Levosulpiride-induced movement disorders. Movement Disorders. 2009; 24(15): 2249–53. DOI: 10.1002/mds.22805
- 17Jankovic J, Casabona J. Coexistent Tardive Dyskinesia and Parkinsonism. Clinical Neuropharmacology. 1987; 10(6): 511–521. DOI: 10.1097/00002826-198712000-00002
- 18Pellegrino M, Sacco M, Lotti F. Extrapyramidal syndrome caused by moderate overdosage of domperidone. Description of a case. Pediatr Med Chir. 1990; 12: 205–6
- 19Franckx J, Noel P. Acute extrapyramidal dysfunction after domperidone administration. Report of a case. Helv Paediatr Acta. 1984; 39: 285–8.
- 20Roy-Desruisseaux J, Landry J, Bocti C, et al. Domperidone induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother. 2011; 45: 51. DOI: 10.1345/aph.1Q214
- 21Ke W, Liu M, Li Y, et al. Extrapyramidal symptoms caused by itopride[J]. Adverse Drug Reactions Journal. 2018; 20(6): 474–5.
- 22Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol. 2005; 4: 866–76. DOI: 10.1016/S1474-4422(05)70250-7
- 23Zadikoff C, Munhoz RP, Asante AN, Politzer N, Wennberg R, Carlen P, Lang A. Movement disorders in patients taking anticonvulsants. Journal of Neurology, Neurosurgery & Psychiatry. 2007; 78(2): 147–51. DOI: 10.1136/jnnp.2006.100222
- 24Giordano A, Amboni M, Tessitore A. Valproate-Induced Generalized Choreoathetosis. Movement Disorders Clinical Practice. 2014; 1(3): 271–72. DOI: 10.1002/mdc3.12069
- 25Harrison MB, Lyons GR, Landow ER. Phenytoin and dyskinesias: a report of two cases and review of the literature. Mov Disord. 1993; 8: 19–27. DOI: 10.1002/mds.870080104
- 26Terland O, Flatmark T. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles. Neuropharmacology. 1999; 38(6): 879–82. DOI: 10.1016/S0028-3908(98)00233-0
- 27Teive HA, Troiano AR, Germiniani FM, Werneck LC. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism & Related Disorders. 2004; 10(4): 243–45. DOI: 10.1016/j.parkreldis.2003.12.004
- 28Micheli F, Pardal MF, Gatto M, Torres M, Paradiso G, Parera IC, Giannaula R. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology. 1987; 37(5): 881. DOI: 10.1212/WNL.37.5.881
DOI: https://doi.org/10.5334/tohm.554 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jul 17, 2020
Accepted on: Sep 24, 2020
Published on: Oct 26, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Anjali Chouksey, Sanjay Pandey, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.